CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 25 enrolled
Drug / intervention
GWP42003 200 mg/day Dose +3 moredrug
Likely dose
GWP42003 200 mg/day Dosefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01284634
NCT01284634Phase 2Completed
CompareCT.gov

A Randomised, Partially-blind, Placebo-controlled, Pilot, Dose-ranging Study To Assess The Effect Of Cannabidiol (CBD) On Liver Fat Levels In Subjects With Fatty Liver Disease.

GW Research Ltd·interventional·Posted Jan 27, 2011·Updated Aug 8, 2018

In Brief

A Phase 2 clinical trial evaluating GWP42003 200 mg/day Dose, GWP42003 400 mg/day Dose, and 2 other interventions for Fatty Liver. Completed, enrolled 25 participants across 3 sites.

Detailed Summary

The purpose of this study is to evaluate the effect of GWP42003 on liver triglyceride (liver fat) in participants with fatty liver disease (FLD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFatty Liver
CountriesUnited Kingdom
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 27, 2011
Enrollment StartMay 3, 2011
Primary CompletionJul 13, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.4 years ago

Interventions

GWP42003 200 mg/day Dosedrug

GWP42003 was presented as Licaps® size double zero (Size 00) hard gelatin capsules containing 100 mg of CBD dissolved in vehicle (Gelucire 44/14).

GWP42003 400 mg/day Dosedrug

GWP42003 was presented as Licaps® Size 00 hard gelatin capsules containing 100 mg of CBD dissolved in vehicle (Gelucire 44/14).

GWP42003 800 mg/day Dosedrug

GWP42003 was presented as Licaps® Size 00 hard gelatin capsules containing 100 mg of CBD dissolved in vehicle (Gelucire 44/14).

Placebodrug

Placebo was presented as Licaps® Size 00 hard gelatin capsules containing excipients (Gelucire 44/14).